Alexandria real estate equities, inc. announces long-term tenant astrazeneca is investing $300 million in a next-generation cell therapy manufacturing facility at the alexandria center for life science - shady grove mega campus in rockville, maryland

Pasadena, calif. , feb. 12, 2024 /prnewswire/ -- alexandria real estate equities, inc. (nyse: are), the first, preeminent, longest-tenured and pioneering owner, operator and developer of collaborative life science, agtech and advanced technology mega campuses in aaa innovation cluster locations, today announced that astrazeneca, a top 20 global biopharmaceutical company and longstanding alexandria tenant, is investing $300 million in a next-generation cell therapy manufacturing facility at 9950 medical center drive on the alexandria center® for life science – shady grove mega campus in the rockville submarket.
ARE Ratings Summary
ARE Quant Ranking